Display options
Share it on

Qual Life Res. 2021 Jul 12; doi: 10.1007/s11136-021-02937-8. Epub 2021 Jul 12.

The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Jessica K Roydhouse, Matthew L Cohen, Henrik R Eshoj, Nadia Corsini, Emre Yucel, Claudia Rutherford, Katarzyna Wac, Allan Berrocal, Alyssa Lanzi, Cindy Nowinski, Natasha Roberts, Angelos P Kassianos, Veronique Sebille, Madeleine T King, Rebecca Mercieca-Bebber,

Affiliations

  1. Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, 7000, Australia. [email protected].
  2. Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, RI, USA. [email protected].
  3. Department of Communication Sciences and Disorders, University of Delaware, Newark, DE, USA.
  4. Department of Hematology, Quality of Life Research Center, Odense University Hospital, Odense, Denmark.
  5. Rosemary Bryant AO Research Centre, University of South Australia, Adelaide, SA, Australia.
  6. Amgen, Global Health Economics, Thousand Oaks, CA, USA.
  7. Bristol Myers Squibb, New York, NY, USA.
  8. Cancer Nursing Research Unit (CNRU), Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  9. School of Psychology, Faculty of Science, The University of Sydney, Sydney, NSW, Australia.
  10. Quality of Life Technologies Lab, University of Geneva, Geneva, Switzerland.
  11. Quality of Life Technologies Lab, University of Copenhagen, Copenhagen, Denmark.
  12. Departments of Medical Social Sciences and Neurology, Northwestern University Feinberg School of Medicine, Evanston, IL, USA.
  13. Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
  14. Queensland University of Technology, Brisbane, QLD, Australia.
  15. Department of Applied Health Research, University College London, London, UK.
  16. SPHERE, University of Nantes, University of Tours, INSERM, Nantes, France.
  17. Department of Methodology and Biostatistics, Nantes University Hospital, Nantes, France.
  18. Faculty of Medicine, Sydney Medical School, Central Clinical School, The University of Sydney, Sydney, NSW, Australia.
  19. NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia.

PMID: 34254262 DOI: 10.1007/s11136-021-02937-8

Abstract

AIMS: Proxy reports are often used when patients are unable to self-report. It is unclear how proxy measures are currently in use in adult health care and research settings. We aimed to describe how proxy reports are used in these settings, including the use of measures developed specifically for proxy reporting in adult health populations.

METHODS: We systematically searched Medline, PsycINFO, PsycTESTS, CINAHL and EMBASE from database inception to February 2018. Search terms included a combination of terms for quality of life and health outcomes, proxy-reporters, and health condition terms. The data extracted included clinical context, the name of the proxy measure(s) used and other descriptive data. We determined whether the measures were developed specifically for proxy use or were existing measures adapted for proxy use.

RESULTS: The database search identified 17,677 possible articles, from which 14,098 abstracts were reviewed. Of these, 11,763 were excluded and 2335 articles were reviewed in full, with 880 included for data extraction. The most common clinical settings were dementia (30%), geriatrics (15%) and cancer (13%). A majority of articles (51%) were paired studies with proxy and patient responses for the same person on the same measure. Most paired studies (77%) were concordance studies comparing patient and proxy responses on these measures.

DISCUSSION: Most published research using proxies has focused on proxy-patient concordance. Relatively few measures used in research with proxies were specifically developed for proxy use. Future work is needed to examine the performance of measures specifically developed for proxies.

SYSTEMATIC REVIEW REGISTRATION: PROSPERO No. CRD42018103179.

© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Keywords: Outcome measures; Proxy measures; Proxy-reported outcomes; Quality of life; Systematic review

References

  1. Rand, S., Caiels, J. (2015). Using proxies to assess quality of life: A review of the issues and challenges. Discussion paper. Quality and outcomes of person-centred care policy research unit (QORU). University of Kent. Retrieved December 1, 2020, from https://kar.kent.ac.uk/55009/1/Proxy%20literature%20review%20report%20FINAL.pdf - PubMed
  2. Jones, J. M., McPherson, C. J., Zimmermann, C., Rodin, G., Le, L. W., & Cohen, S. R. (2011). Assessing agreement between terminally ill cancer patients’ reports of their quality of life and family caregiver and palliative care physician proxy ratings. Journal of Pain and Symptom Management, 42(3), 354–365. - PubMed
  3. Cohen, M. L., & Hula, W. D. (2020). Patient-reported outcomes and evidence-based practice in speech-language pathology. American Journal of Speech-Language Pathology, 29(1), 357–370. - PubMed
  4. Food and Drug Administration. (2009). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Silver Spring, MD: Food and Drug Administration. Retrieved December 1, 2020, from https://www.fda.gov/media/77832/download - PubMed
  5. European Medicines Agency. (2016). Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: The use of patient-reported outcome (PRO) measures in oncology studies. London, UK: European Medicines Agency. Retrieve December 1, 2020, from https://www.ema.europa.eu/en/documents/other/appendix-2-guideline-evaluation-anticancer-medicinal-products-man_en.pdf - PubMed
  6. Powers, J. H., 3rd., Patrick, D. L., Walton, M. K., Marquis, P., Cano, S., Hobart, J., Isaac, M., Vamvakas, S., Slagle, A., Molsen, E., & Burke, L. B. (2017). Clinician-reported outcome assessments of treatment benefit: Report of the ISPOR clinical outcome assessment emerging good practices task force. Value in Health, 20(1), 2–14. - PubMed
  7. Food and Drug Administration. (2018). Attachment to discussion document for patient-focused drug development public workshop on guidance 3: Select, develop or modify fit-for-purpose clinical outcome assessments—Appendices 2018. Silver Spring, MD: Food and Drug Administration. Retrieved August 4, 2020, from https://www.fda.gov/media/116281/download - PubMed
  8. Hanson, L. C., Bennett, A. V., Jonsson, M., Kelley, A., Ritchie, C., Saliba, D., Teno, J., & Zimmerman, S. (2020). Selecting outcomes to ensure pragmatic trials are relevant to people living with dementia. Jounal of American Geriatrics Society, 68(Suppl 2), S55–S61. - PubMed
  9. Pickard, A. S., & Knight, S. J. (2005). Proxy evaluation of health-related quality of life: A conceptual framework for understanding multiple proxy perspectives. Medical Care, 43(5), 493–499. - PubMed
  10. Matza, L. S., Patrick, D. L., Riley, A. W., Alexander, J. J., Rajmil, L., Pleil, A. M., & Bullinger, M. (2013). Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value in Health, 16(4), 461–479. - PubMed
  11. De Los Reyes, A., Thomas, S. A., Goodman, K. L., & Kundey, S. M. (2013). Principles underlying the use of multiple informants’ reports. Annual Review of Clinical Psychology, 9, 123–149. - PubMed
  12. Grill, J. D., Zhou, Y., Karlawish, J., & Elashoff, D. (2015). Frequency and impact of informant replacement in Alzheimer disease research. Alzheimer Disease and Associated Disorders, 29(3), 242–248. - PubMed
  13. Gruber-Baldini, A. L., Shardell, M., Lloyd, K. D., & Magaziner, J. (2012). Use of proxies and informants. In A. B. Newman & J. A. Cauley (Eds.), The epidemiology of aging (pp. 81–90). Springer. - PubMed
  14. Mercieca-Bebber, R., Williams, D., Tait, M. A., Rutherford, C., Busija, L., Roberts, N., Wilson, M., Sundaram, C. S., & Roydhouse, J. (2019). Trials with proxy-reported outcomes registered on the Australian New Zealand clinical trials registry (ANZCTR). Quality of Life Research, 28(4), 955–962. - PubMed
  15. Evans, C. J., Benalia, H., Preston, N. J., Grande, G., Gysels, M., Short, V., Daveson, B. A., Bausewein, C., Todd, C., & Higginson, I. J. (2013). The selection and use of outcome measures in palliative and end-of-life care research: the MORECare international consensus workshop. Journal of Pain and Symptom Management, 46(6), 925–937. - PubMed
  16. Graham, C. (2016). Incidence and impact of proxy response in measuring patient experience: Secondary analysis of a large postal survey using propensity score matching. International Journal for Quality in Health Care, 28(2), 246–252. - PubMed
  17. Bjertnaes, O. (2014). Patient-reported experiences with hospitals: Comparison of proxy and patient scores using propensity-score matching. International Journal for Quality in Health Care, 26(1), 34–40. - PubMed
  18. Todorov, A., & Kirchner, C. (2000). Bias in proxies’ reports of disability: Data from the National Health Interview Survey on disability. American Journal of Public Health, 90(8), 1248–1253. - PubMed
  19. Chawla, N., Urato, M., Ambs, A., Schussler, N., Hays, R. D., Clauser, S. B., Zaslavsky, A. M., Walsh, K., Schwartz, M., Halpern, M., Gaillot, S., Goldstein, E. H., & Arora, N. H. (2015). Unveiling SEER-CAHPS(R): a new data resource for quality of care research. Jounal of General Internal Medicine, 30(5), 641–650. - PubMed
  20. Sneeuw, K. C., Aaronson, N. K., Sprangers, M. A., Detmar, S. B., Wever, L. D., & Schornagel, J. H. (1998). Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. Journal of Clinical Epidemiology, 51(7), 617–631. - PubMed
  21. Sneeuw, K. C., Aaronson, N. K., de Haan, R. J., & Limburg, M. (1997). Assessing quality of life after stroke. The value and limitations of proxy ratings. Stroke, 28(8), 1541–1549. - PubMed
  22. Sneeuw, K. C., Aaronson, N. K., Osoba, D., Muller, M. J., Hsu, M. A., Yung, W. K. A., Brada, M., & Newlands, E. S. (1997). The use of significant others as proxy raters of the quality of life of patients with brain cancer. Medical Care, 35(5), 490–506. - PubMed
  23. Pickard, A. S., Johnson, J. A., Feeny, D. H., Shuaib, A., Carriere, K. C., & Nasser, A. M. (2004). Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and health utilities index. Stroke, 35(2), 607–612. - PubMed
  24. Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4, 1. - PubMed
  25. Lobchuk, M. M., & Degner, L. F. (2002). Patients with cancer and next-of-kin response comparability on physical and psychological symptom well-being: Trends and measurement issues. Cancer Nursing, 25(5), 358–374. - PubMed
  26. McPherson, C. J., & Addington-Hall, J. M. (2003). Judging the quality of care at the end of life: Can proxies provide reliable information? Social Science and Medicine, 56(1), 95–109. - PubMed
  27. Sneeuw, K. C., Sprangers, M. A., & Aaronson, N. K. (2002). The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. Journal of Clinical Epidemiology, 55(11), 1130–1143. - PubMed
  28. Sprangers, M. A., & Aaronson, N. K. (1992). The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. Journal of Clinical Epidemiology, 45(7), 743–760. - PubMed
  29. Tang, S. T., & McCorkle, R. (2002). Use of family proxies in quality of life research for cancer patients at the end of life: A literature review. Cancer Investigation, 20(7–8), 1086–1104. - PubMed
  30. von Essen, L. (2004). Proxy ratings of patient quality of life–factors related to patient-proxy agreement. Acta Oncologica, 43(3), 229–234. - PubMed
  31. Roydhouse, J. K., & Wilson, I. B. (2017). Systematic review of caregiver responses for patient health-related quality of life in adult cancer care. Quality of Life Research, 26(8), 1925–1954. - PubMed
  32. Liebzeit, D., King, B., & Bratzke, L. (2018). Measurement of function in older adults transitioning from hospital to home: An integrative review. Geriatric Nursing, 39(3), 336–343. - PubMed
  33. Mayo, N. E., Figueiredo, S., Ahmed, S., & Bartlett, S. J. (2017). Montreal accord on patient-reported outcomes (PROs) use series—Paper 2: Terminology proposed to measure what matters in health. Journal of Clinical Epidemiology, 89, 119–124. - PubMed
  34. McKown, S., Acquadro, C., Anfray, C., Arnold, B., Eremenco, S., Giroudet, C., Martin, M., & Weiss, D. (2020). Good practices for the translation, cultural adaptation, and linguistic validation of clinician-reported outcome, observer-reported outcome, and performance outcome measures. Journal of Patient Reported Outcomes, 4(1), 89. - PubMed
  35. Mayo, N. E. (Ed.). (2015). Dictionary of quality of life and health outcomes measurement. ISOQOL. - PubMed
  36. Cappelleri, J. C., Zou, K. H., Bushmakin, A. G., Alvir, J. M. J., Alemayehu, D., & Symonds, T. (2014). Patient-reported outcomes: measurement, implementation and interpretation. CRC Press. - PubMed
  37. Caiels, J., Rand, S., Crowther, T., Collins, G., & Forder, J. (2019). Exploring the views of being a proxy from the perspective of unpaid carers and paid carers: Developing a proxy version of the adult social care outcomes toolkit (ASCOT). BMC Health Services Research, 19, 201. - PubMed
  38. Moher, D., Pham, B., Klassen, T. P., Schulz, K. F., Berlin, J. A., Jadad, A. R., & Liberati, A. (2000). What contributions do languages other than English make on the results of meta-analyses? Journal of Clinical Epidemiology, 53(9), 964–972. - PubMed
  39. Kinghorn, P., & Afentou, N. (2020). Proxy responses to ICECAP-A: exploring variation across multiple proxy assessments of capability well-being for the same individuals. PLoS ONE, 15(7), e0236584. - PubMed
  40. Roydhouse, J. K., Gutman, R., Keating, N. L., Mor, V., & Wilson, I. B. (2018). Differences between proxy and patient assessments of cancer care experiences and quality ratings. Health Services Research, 53(2), 919–943. - PubMed
  41. Roydhouse, J. K., Gutman, R., Keating, N. L., Mor, V., & Wilson, I. B. (2018). Proxy and patient reports of health-related quality of life in a national cancer survey. Health and Quality of Life Outcomes, 16(1), 6. - PubMed
  42. Roydhouse, J. K., Gutman, R., Wilson, I. B., Kehl, K. L., & Keating, N. L. (2020). Patient and proxy reports regarding the experience of treatment decision-making in cancer care. Psycho-Oncology, 29(11), 1943–1950. - PubMed
  43. Smith, G. E., & Bondi, M. W. (2013). Mild cognitive impairment and dementia: definitions, diagnosis, and treatment. Oxford University Press. - PubMed
  44. Alzheimers Association. (2020). 2020 Alzheimer’s disease facts and figures. Alzheimers Dement. - PubMed
  45. Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson’s disease. Movement Disorders, 20(10), 1255–1263. - PubMed

Publication Types